Barclays Downgrades Definitive Healthcare to Underweight, Maintains Price Target to $4
Benzinga Newsdesk 1 year ago
NewsDowngradesPrice TargetAnalyst Ratings
Barclays analyst Saket Kalia downgrades Definitive Healthcare (NASDAQ:DH) from Equal-Weight to Underweight and maintains the price target from $4 to $4.
Barclays analyst Saket Kalia downgrades Definitive Healthcare (NASDAQ:DH) from Equal-Weight to Underweight and maintains the price target from $4 to $4.